EDGAR Filing Documents for 0001493152-21-006609

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001493152-21-006609

Filing Date

2021-03-23

Accepted

2021-03-23 13:44:00

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		form424b3.htm	424B3	7000116
2		image_001.jpg	GRAPHIC	3518
3		image_002.jpg	GRAPHIC	3058
4		image_003.jpg	GRAPHIC	3772
5		image_004.jpg	GRAPHIC	5516
6		image_008.jpg	GRAPHIC	10934
7		pg201-250_001.jpg	GRAPHIC	32604
8		pg201-250_002.jpg	GRAPHIC	44022
9		pg201-250_003.jpg	GRAPHIC	21502
10		pg201-250_004.jpg	GRAPHIC	45782
11		pg201-250_005.jpg	GRAPHIC	21410
12		pg201-250_006.jpg	GRAPHIC	18932
13		pg201-250_007.jpg	GRAPHIC	26920
14		pg201-250_008.jpg	GRAPHIC	8333
15		pg201-250_009.jpg	GRAPHIC	14233
16		pg201-250_010.jpg	GRAPHIC	9832
17		mymd_001.jpg	GRAPHIC	212366
18		mymd_002.jpg	GRAPHIC	117074
19		supera_001.jpg	GRAPHIC	206151
20		annexf_001.jpg	GRAPHIC	243732
21		annexf_002.jpg	GRAPHIC	178345
22		annexm_001.jpg	GRAPHIC	156749
	Complete submission text file	0001493152-21-006609.txt		8910799

Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036

Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 856-848-8698

Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)